Literature DB >> 10918219

Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers.

S A Abd-El-Aleem1, M W Ferguson, I Appleton, S Kairsingh, E B Jude, K Jones, C N McCollum, G W Ireland.   

Abstract

Chronic venous ulcers, an example of abnormal wound healing, show chronic inflammation with defective matrix deposition which together with the underlying vascular pathology, result in delayed healing. L-arginine is known to be metabolized by one of two pathways: nitric oxide synthase (NOS), producing nitric oxide (NO), or arginase, producing ornithine. NO is involved in many pathological conditions including vascular and inflammatory disorders. This study therefore investigated the distribution, level and activity of NOS and arginase in chronic venous ulcers in comparison with normal skin, using immunocytochemistry, western blotting, and enzyme assays. The results demonstrated an increased distribution of both NOS and arginase in chronic venous ulcer tissue compared with normal skin, with inflammatory cells and vascular endothelial cells as the main sources. These data were confirmed by western blot analysis, which showed increased levels of both enzymes in chronic venous ulcers. Moreover, there was significantly increased activity of both total NOS (p<0.04) and inducible NOS (p<0.05) in chronic venous ulcer tissue compared with normal skin, and significantly increased activity of arginase (p<0.01) in chronic venous ulcer tissue in comparison with normal skin. NO is known to combine with hydroxyl free radicals forming peroxynitrite, a potent free radical which causes tissue destruction. NO overexpression in chronic venous ulcers may be involved directly or indirectly (through production of peroxynitrite) in the pathogenesis and delayed healing of chronic venous ulcers, through its effects on vasculature, inflammation, and collagen deposition. Arginase is known to enhance matrix deposition. Thus, increased levels of arginase in chronic venous ulcers could contribute to the pathogenesis of lipodermatosclerosis associated with chronic venous insufficiency, predisposing to the formation of chronic venous ulcers and also to matrix cuff formation around blood vessels. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918219     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.

Authors:  Laura Campbell; Elaine Emmerson; Helen Williams; Charis R Saville; Andrée Krust; Pierre Chambon; Kimberly A Mace; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

2.  Healing of leg ulcers associated with transjugular intrahepatic portosystemic shunt in decompensated cirrhosis: case series of a possible hepatodermal syndrome.

Authors:  Cherif M El Younis; Nora V Bergasa
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

3.  Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.

Authors:  Vikki G Nolan; Adeboye Adewoye; Clinton Baldwin; Ling Wang; Qianli Ma; Diego F Wyszynski; John J Farrell; Paola Sebastiani; Lindsay A Farrer; Martin H Steinberg
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 4.  The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism.

Authors:  M Kapoor; A N Clarkson; B A Sutherland; I Appleton
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series.

Authors:  Kenneth Blum; Amanda Lh Chen; Thomas Jh Chen; B William Downs; Eric R Braverman; Mallory Kerner; Stella Savarimuthu; Anish Bajaj; Margaret Madigan; Seth H Blum; Gary Reinl; John Giordano; Nicholas Dinubile
Journal:  Cases J       Date:  2010-02-10

6.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.

Authors:  Anca Sindrilaru; Thorsten Peters; Stefan Wieschalka; Corina Baican; Adrian Baican; Henriette Peter; Adelheid Hainzl; Susanne Schatz; Yu Qi; Andrea Schlecht; Johannes M Weiss; Meinhard Wlaschek; Cord Sunderkötter; Karin Scharffetter-Kochanek
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

7.  Substance P enhances wound closure in nitric oxide synthase knockout mice.

Authors:  Pornprom Muangman; Richard N Tamura; Lara A Muffley; F Frank Isik; Jeffrey R Scott; Chengyu Xie; Gary Kegel; Stephen R Sullivan; Zhi Liang; Nicole S Gibran
Journal:  J Surg Res       Date:  2008-05-16       Impact factor: 2.192

8.  Characterization of a preclinical model of chronic ischemic wound.

Authors:  Sashwati Roy; Sabyasachi Biswas; Savita Khanna; Gayle Gordillo; Valerie Bergdall; Jeanne Green; Clay B Marsh; Lisa J Gould; Chandan K Sen
Journal:  Physiol Genomics       Date:  2009-03-17       Impact factor: 3.107

9.  Hyperbaric oxygen reduces matrix metalloproteinases in ischemic wounds through a redox-dependent mechanism.

Authors:  Qixu Zhang; Lisa J Gould
Journal:  J Invest Dermatol       Date:  2013-07-18       Impact factor: 8.551

10.  Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats.

Authors:  Mohit Kapoor; Rowena Howard; Irene Hall; Ian Appleton
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.